Browse By: Country ι Category ι Latest Reports ι Tag

Bioinformatics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018

Pages » 127
Published By » Transparency
Price » $4595
In stock
View Report Details
Description

The “Bioinformatics Market – Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012 – 2018” report includes study of the global market for bioinformatics across different sub segments and geographies. The report analyzes the global bioinformatics market growth across various segments such as knowledge management tools, platforms, and services. The in-depth analysis includes analysis of sub-segments up to three levels, with cross sectional analysis on the basis of geographical and regional market size and forecasts. The cross-sectional analysis of the global bioinformatics market based on applications further provides market growth potential across... Click here for more details


Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
GBI Research\'s report, “Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies”, provides the key data and analyzes the major challenges and drivers for the biomanufact
Published Date: Sep 2010
Price: $3500
Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth
GBI Research, the leading business intelligence provider, has released its latest report, “Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth” that provides key data, information and analysis of the major trends and issues affecti
Published Date: Sep 2010
Price: $3500
Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential
GBI Research, the leading business intelligence provider, has released its latest report, “Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential” that provides key data, information and analysis of the major trends and issues in
Published Date: Dec 2010
Price: $3500
Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions
GBI Research, the leading business intelligence provider, has released its latest report, “Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions” that provides key data, information and analysis of the major trends and
Published Date: Dec 2010
Price: $3500
Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
GBI Researchs new report, Early Stage Drug Development in Disease Segments Innovation Focuses on Stem Cell Therapies and Gene Therapies, provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immu
Published Date: Feb 2011
Price: $3500
Biobanks - 2011 Yearbook
GBI Research, the leading business intelligence provider, has released its latest research, Biobanks - 2011 Yearbook. It provides key data, information and analysis of the 40 major biobanks in the world. The report provides information on the population-based biobanks, disease based biobanks, brai
Published Date: Mar 2011
Price: $3500
Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology
GBI Research, the leading business intelligence provider, has released its latest research Clinical Trial Endpoints in Oncology Inclusion of Surrogate Endpoints and Shorter Endpoints will Ensure Faster Clinical Trials in Oncology, which essentially provides insights into clinical trial endpoints i
Published Date: Mar 2011
Price: $3500
Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment
GBI Research, the leading business intelligence provider, has released its latest report, Biosimilars Approval Pathways in the US and Europe Development and Approval of Biosimilar mAbs May Face Tough Regulatory Environment that provides key data, information and analysis of the major trends and is
Published Date: Apr 2011
Price: $3500
Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars
GBI Research, the leading business intelligence provider, has released its latest research, Cancer Supportive Care Products Market to 2016 Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars, which provides insights into the cancer supportive care products mark
Published Date: Apr 2011
Price: $3500
Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics
GBI Researchs new report, Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics provides key data, information and analysis on the Orthobiologics industry and analytical content on the market dynamics. The report provides mar
Published Date: Jun 2011
Price: $3500

 


 

Related News

Upfront Payout of US$65 Million for Isis Pharma
Isis Pharmaceuticals continues to expand into multiple disease sectors, in which the latest move includes the signing of a top level drug development partnership with another drug company. The new partnership with AstraZeneca will get US$65 million to Carlsbad biotech upfront. The deal also calls for Isis Pharma to discover and work on drugs that are useful in cardiovascular, kidney, and metabolic diseases. They are to develop these drugs using the antisense technology developed by Isis. I
Date: Aug 03

16.59% Rally of China Pharma Holdings’ Shares
China Pharma Holdings, Inc. company shares rose by 16.59% in the previous week. The pharma company still tallied to a loss of 23.53% during the past four weeks. The company share did surpass the S&P 500 in the previous week by 15.25%. However, they have underperformed the index by 24.51% within the last four weeks. China Pharma Holdings, Inc. shares have slowed down by 29.73% within the previous three month period. The current year-on-year performance is -13.36%. The company shares
Date: Aug 03

Japan Promotes Higher Education to Improve the Skills of the Graduates
Shinzo Abe, the Prime Minister of Japan, is aiming to develop better-skilled graduates by retooling the public universities. The main motto is to transform the government-funded universities of Japan into scientific research centers, schools or global leaders. Japan’s Universities are planning to achieve this target by restructuring the curricula and redefining the missions. In June, all 86 of Japan’s national level universities were asked to submit their refined plans by the educ
Date: Aug 03

Hong Kong Ranked Fourth Amongst the 148 Most Popular Arbitral Venues
Cross-border investments, in the recent past, led to complex relations amongst the commercial parties. Commercial parties are moreover depending on the international arbitration to solve respective disputes. Hong Kong, for many reasons, is considered to be the most attractive arbitral venue in Asia Pacific.  As per the World Economic Forum Global Competitiveness Report, published for year 2013-2014, Hong Kong is ranked fourth amongst the 148 jurisdictions. Hong Kong is supposedly ahead o
Date: Aug 03

Slump in Oil and Gas Industry Taking Toll on Industry Economy
As the shippers, drivers, and airlines maintain to enjoy the lower fuel prices, the oil industry is broadly responding to extremely lower profits with high cuts in employment and spending. These cuts are affecting the economic growth.    Low gas and oil prices are beneficial for the overall economy. They help to reduce the costs for business and consumers. As the U.S. economic growth was extremely higher in the second quarter, the economists express that was partially boosted by the
Date: Aug 03

JX Holdings’ Sets its Summer Agenda toward Uproar in Oil Industry
The competition between companies in the global market is becoming more and more intense, day by day. The competition is growing both in domestic and overseas markets.  Yomiuri Shimbun, staff writer requested new leaders about their agenda for this summer. These leaders who took office at the top of the various companies this year were informed about the same.  Of all the companies, the star performer has reached the top and taken the stage. President Yukio Uchida, JX Holdings In
Date: Aug 03

HSBC Reports 10% Increase in Profit for 1st Half of 2015
HSBC Holdings has reported a rise in its profit for the first-half of 2015 by 10%. In a press note issued of Aug 03, 2015, the biggest bank in Europe has stated that the robust performance has helped the company to boost its revenue. In the same note, the bank has also announced the sale of its Brazilian unit for US$5.2 billion. The profit for H1 of 2015 has increased to 48 cents per share, summing up to US$13.6 billion in a whole, stated the bank. The revenue of the bank has increased by 4%
Date: Aug 03

China Plan to Tighten Regulations to Control Online Payment
China has plans to tighten the regulations that governs the country’s 270 online-payment enterprises such as Alibaba. This move has come as another blow to the flourishing Internet business for finance. Under the draft rules issued on July 31, 2015, the central bank is likely to limit the amount that a person can pay online through a third-party payment account to US$805 per day, crossing which, the customer would need to verify his/her identity via an electronic signature and security
Date: Aug 03

Walmart to Further Invest in E-commerce Business in China
The e-commerce market of China has not been a very easy one for Walmart to crack into, however the American retail giant is in no way giving in. On the contrary, Walmart has begun investing a lot more towards the e-commerce operations that it had initiated there, and in a way has taken total control of a particular China-based online retailer.  Walmart, on Thursday ended up purchasing the leftover shares of the Chinese company called Yihaodian. This was after it was seen that Walmart was
Date: Jul 31

Inflatable Device to Help Obese Patients Lose Weight gets FDA Approval
The United States Food and Drug Administration has given its approval for an inflatable device that can help patients suffering from obesity shed their weight without any surgeries. The balloon, made by Reshape Medical, will be inserted inside the body and fill a portion of the stomach.  A minimally invasive endoscopic procedure will be performed by doctors, where in they will go in through the mouth to reach the stomach and implant the device. Typically, the procedure will take less tha
Date: Jul 31

Upcoming Reports

Hormone Replacement Therapy Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Hormone replacement therapy (HRT) is administration of hormones to those patients who are under a phase of declining natural hormones in their body. Hormone replacement therapy is mostly administered to women undergoing menopausal phase. The hormones which are administered to patients are most
Published By: Transparency
Price: $4795
Bio-Implants Market - Global Industry Analysis, Market Size, Market Share And Forecast, 2012 - 2018
Bio-implants are bioengineered products known to be of human or animal origin used in the different fields of ENT. Generally, these bio-implants are offered for safeguarding after tissue replacement. These bio-implants are made up of biosynthetic materials known as collagen or it can also be made
Published By: Transparency
Price: $4795
Biobanks Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Biobanks is a collection or storation of blood and cell samples from a large number of people. Biobank collection denotes its use in medical field and research. The global biobank industry is segmented into different sectors such as human tissue banking, or population banking, stem cell banking, c
Published By: Transparency
Price: $4795
Orthobiological Products Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global orthobiological products market is expected to grow to $15.3 billion by the year 2022 as a result of tremendous growth in the medical devices industry mainly due to increase in aging population. Growth of orthobiological products is driven by increasing awareness towards adoption of ort
Published By: Transparency
Price: $4795
Gene Amplification Technologies Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
Gene amplification technology is proving to be an important technology in human genome projects and other important fields like diagnostics. There are number of companies involved in the business of gene amplification and diagnostics with over 30 gene and signal amplification technologies. These g
Published By: Transparency
Price: $4795
DNA Sequencing Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global DNA sequencing market is forecast to grow to $6.6 billion over the year 2016 at the compounded annual growth rate of 17.5% as a result of emerging technologies in this field and its use in a number of applications.   DNA sequencing industry is segmented into instruments and consu
Published By: Transparency
Price: $4795
Epigenetics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global epigenetics market is projected to reach the value of $18.2 billion by the year 2015 driven by investigation of factors influencing cellular malfunction and disease development. Also, developments in epigenetic studies like biomarker discovery and scientifically useful biomarker tests a
Published By: Transparency
Price: $4795
Biologics Market - G7 Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
With an increase in the number of clinical trials in the past 5 years, the market for biologics is expected to witness a high growth during the coming years. Monoclonal antibodies, vaccines and therapeutic proteins will contribute significantly to the growth in the biologics market. The global
Published By: Transparency
Price: $4795
Biosimilar and Follow-On Biologics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new heights. Drug manufacturers are exploring the possibilities of producing generic biopharmaceuticals drugs with a motive of reducing the prices of thes
Published By: Transparency
Price: $4795
Biopesticides Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
Biopesticides are essential for controlling the effect of agricultural pests, insects, and bacterial and fungal growth on food and field crops. Use of biopesticides can avoid the hazards caused by the use of chemical pesticides on the environment. Growing environmental concerns and stringent r
Published By: Transparency
Price: $4795